The Vaccine Group is proud to announce that Dr Michael Jarvis, TVG’s Chief Scientific Officer, has been recognised in the

Trial data show strong T cell responses to SARS-CoV-2, as well as the more divergent SARS-CoV-1, demonstrating potential for broad

The Vaccine Group (“TVG” or the “Company”) is pleased to announce the appointment of Dr Jeremy Salt as Chief Executive Officer. Jeremy has

The Vaccine Group (“TVG” or the “Company”) today announces it is to collaborate with The Pirbright Institute  (“Pirbright” or the